Procter & Gamble Health Ltd - Company Profile
Powered by 
All the sales intelligence you need on Procter & Gamble Health Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Procter & Gamble Health Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Procter & Gamble Health Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Procter & Gamble Health Ltd (P&G Health), a subsidiary of Procter & Gamble Overseas India BV, is a manufacturer and marketer of pharmaceutical products. The company’s product portfolio comprises over-the-counter products, minerals, vitamins, and supplement products for an improved quality of life and healthy lifestyle. It markets products under the Neurobion, Polybion, Cosome, Evion, Livogen, Nasivion and Seven Seas brand names. The company manufactures pharma and chemical products at its own production facility in Usgaon, Goa, India, and third-party managed production sites. It exports pharmaceutical products to Asian countries such as Nepal, Maldives, Myanmar, and Sri Lanka, and outside Asia. P&G Health is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
Godrej One, 8th Floor Pirojshanagar, Vikhroli (East), Mumbai, Maharashtra, 400099
Website
www.pghealthindia.com
Telephone
91 22 62109000
No of Employees
1,326
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
PGHL (NSE)
Revenue (2025)
$111.7M
-18.9%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
16.6%
(2025 vs 2024)
Market Cap*
$1.1B
Net Profit Margin (2025)
XYZ
43.7%
(2025 vs 2024)
* As of and is in US$
Procter & Gamble Health Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Over-The-Counter Products | Evion |
| Vitamins | Nasivion |
| Minerals | Seven Seas |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In March 2025, Health and Indian Medical Association (IMA) launch ‘India’s First Patient Recovery Guidelines’ for Doctors. |
| 2024 | Contracts/Agreements | In April, the company entered into a partnership with HelpAge India to establish a New Mobile Healthcare Unit at Palghar in Maharashtra, India. |
| 2024 | New Products/Services | In March, the company and Obesity International introduced Language of Diabetes. |
Competitor Comparison
| Key Parameters | Procter & Gamble Health Ltd | Abbott India Ltd | GlaxoSmithKline Pharmaceuticals Ltd | Sanofi India Ltd | Amway India Enterprises Pvt Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Mumbai | Mumbai | Mumbai | New Delhi |
| State/Province | Maharashtra | Maharashtra | Maharashtra | Maharashtra | Delhi |
| No. of Employees | 1,326 | 3,659 | 3,113 | 991 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| S. Madhavan | Chairman | Executive Board | 2025 | - |
| Shashank Srowthy | Director; Chief Financial Officer | Executive Board | 2025 | - |
| Milind Thatte | Director; Managing Director | Executive Board | 2018 | - |
| Zeal Shah | Chief Compliance Officer; Secretary | Senior Management | 2021 | - |
| Seema Sambasivan | Director | Non Executive Board | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer